"It is a significant vote of confidence in the future growth prospects of our pharmaceuticals business in India". Read on..- David Redfern, GSK's chief strategy officer.
India is abysmal when it comes to ease of doing business. Will it ever change? Here's what Manoj Ladwa would do.Read More...
Sign up to our FREE Weekly News Digest